![Christopher Starr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Christopher M.
Starr was the founder of Horizon Pharmaceutical LLC, founded in 2009, serving as Independent Director from 2015 to 2016.
Dr. Starr is the founder of Monopar Therapeutics, Inc., founded in 2014, serving as Executive Chairman since 2014.
Dr. Starr was the founder of BioMarin Pharmaceutical, Inc., founded in 1997, serving as Chief Scientific Officer & VP-R&D.
Dr. Starr was the founder of Raptor Pharmaceuticals Corp., founded in 2005, serving as Director from 2014 to 2016.
Current jobs include Chief Executive Officer at Raptor Discoveries, Inc. since 2005, Chairman at Thiogenesis Therapeutics, Inc., and Chairman at Thiogenesis Therapeutics Corp.
since 2022.
Former jobs include Executive Chairman at Glycomine, Inc. in 2016, Vice President-Research & Development at Glyko, Inc. from 1991 to 1998, and Associate at The National Research Council and National Institutes of Health.
Education includes a doctorate from SUNY Upstate Medical University and an undergraduate degree from Syracuse University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MONOPAR THERAPEUTICS INC 0,22 % | 31/03/2026 | 15.053 ( 0,22 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Fundador | 01/12/2014 |
| THIOGENESIS THERAPEUTICS, CORP. | Presidente | 31/03/2022 |
Raptor Discoveries, Inc. | Director Ejecutivo | 08/09/2005 |
| Empresas | Cargo | Fin |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Fundador | 25/10/2016 |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Fundador | 01/10/2016 |
| BIOMARIN PHARMACEUTICAL INC. | Fundador | 01/01/2006 |
Glyko, Inc.
 Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Director Técnico/Científico/I+D | 01/01/1998 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Glyko, Inc.
Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Health Technology |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy consulting and advice | Commercial Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Discoveries, Inc. | |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Health Technology |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
